Dr Reddy's Laboratories on Thursday said the US health regulator is conducting an inspection of its Hyderabad-based R&D facility.
"We would like to inform you that the US Food and Drug Administration (USFDA) has commenced an inspection at our R&D facility in Bachupally, Hyderabad, and the outcome of the same will be updated and necessary disclosure will be made with the stock exchanges," it said in a regulatory filing.
The company proactively discloses the outcome of every USFDA inspection to the stock exchanges immediately after the end of the inspection, it added.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Shares of the company were trading 1.2% up at Rs 5,796.40 apiece on the BSE.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
